Federal Supply Schedule 36F79724D005E
Award Date
12/17/23
Last Date to Order
2/13/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Phlow Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Exela Pharma Sciences, LLC, provides a broad range of drugs, pharmaceuticals, and hematology-related products for the VA's Veterans Integrated Service Network 12. The multiple-award contract (ID: 36F79724D0210) has a ceiling value of $20,304,570.00 and a period of performance from September 29, 2024, to September 28, 2029. As a minority-owned, self-certified small disadvantaged business, Exela...
Phathom Pharmaceuticals, Inc. has been awarded a Federal Supply Schedule (FSS) contract IDV by the Department of Veterans Affairs (VA) to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract, awarded to the for-profit manufacturer of goods, has a ceiling value of $25,000 and a period of performance from January 2, 2024, to June 30, 2024. This is an interim agreement to enable the VA's Veterans Integrated Service Network 12 to issue task orders...
The U.S. Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract IDV to Phathom Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical and hematology-related products. The $250,000 multiple-award contract (36F79724D0154) enables the VA's Veterans Integrated Service Network 12 to procure drugs, pharmaceuticals, and hematology products under the Federal Supply Classification code 65 I B. The contract has a period of performance from July 1, 2024, to June...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule. The contract has a ceiling value of $1,870,730,000.00 and was awarded to Viiv Healthcare Company, a foreign-owned, for-profit manufacturer of goods. The contract has a period of performance from August...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract to Richmond Pharmaceuticals, Inc., a woman-owned small business, under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The $39 million multiple award contract has a period of performance through February 2029, enabling the VA's Veterans Integrated Service Network (VISN) 12 to procure a broad portfolio of pharmaceuticals, drugs, and hematology supplies from Richmond Pharmaceuticals...